Researchers Publish Results of Largest Genome-Wide Linkage Study of 
Prostate Cancer Among African American Men


Collaborative effort may open doors to improved diagnosis and 
treatment

10-11-2006

Phoenix, AZ, October 11, 2006--Researchers from 14 institutions 
across the country today announced the results of the first genome-
wide linkage study of prostate cancer in African Americans. Using 
genetic markers, researchers identified several regions of the human 
genome that likely contain genes that, when altered, increase the 
risk of developing prostate cancer. 
The study was conceived, implemented and executed primarily by 
African American investigators. Published in the journal, The 
Prostate, the AAHPC is a milestone in years of research designed to 
identify genetic risk factors for prostate cancer and to help 
determine if heredity plays a role in the disparity in prostate 
cancer rates seen among African American men. 

The African American Hereditary Prostate Cancer Study Network 
(AAHPC) recruited 77 African American extended families, which 
encompassed a total of 418 men with prostate cancer, to participate 
in this study. All of the families studied had at least four men who 
have been diagnosed with prostate cancer. Using genetic markers, 
researchers were able to map several important regions of the human 
genome that likely contain genes that, when mutated, predispose 
these men to developing prostate cancer. 

"We now must sift through millions of bases of genome sequence to 
identify the proverbial 'needle in the haystack'," said John 
Carpten, PhD, senior author and director of TGen's Integrated Cancer 
Genomics Division. "The discovery of these genes will hopefully lead 
to new and improved modes of diagnosis and treatment for some men 
with prostate cancer. This work speaks to our committed efforts to 
help reduce the disparity in prostate cancer rates seen among 
African American men." 

According to the National Cancer Institute, the incidence of 
prostate cancer among African American men is 277 per 100,000 
compared to 168 per 100,000 for white men. The annual death rate 
from prostate cancer is 73 per 100,000 for African American men 
compared 30 per 100,000 for white men. This means that the incidence 
of prostate cancer is about two times higher in African American men 
who are three times more likely to die from this disease. Family 
history is the most significant risk factor known for prostate 
cancer among all men, including African Americans. 

"We hope today's findings-and the discoveries we expect to make in 
future years-will inspire the worldwide research community to view 
this study as a model for many other genetic studies of common 
diseases," said Francis S. Collins, MD, PhD, director of the 
National Human Genome Research Institute (NHGRI), which is part of 
the National Institutes of Health. "Not only does this study 
represent one of the most impressive collections of prostate cancer 
families from any ethnic group, it demonstrates the importance of 
setting up a network of principal investigators who are close to the 
community under study." 

The paper's first author, Agnes B. Baffoe-Bonnie, MD, MPH, PhD, who 
is an associate member at the Population Science Division at the Fox 
Chase Cancer Center (FCCC) in Philadelphia, said these findings 
greatly add to our understanding of hereditary prostate cancer in 
African Americans. "I commend the many families who took the time to 
participate in this important research and praise their commitment 
to advancing medical knowledge. These important findings will be 
applied to prevention and treatment strategies," Dr. Baffoe-Bonnie 
said. 

AAHPC is the largest study to date that focuses on prostate cancer 
in African American families. The families studied came from 
Chicago, Detroit, Houston, New York, Washington, D.C., Atlanta and 
South Carolina. 

"Since this disease is so important in this population, this is a 
critical study in terms of our ability to understand the molecular 
mechanisms responsible for the disproportionate risk observed in 
African American men for both diagnosis of and mortality from 
prostate cancer," said William B. Isaacs, PhD, of Johns Hopkins 
University School of Medicine in Baltimore, who is head of the 
International Consortium for Prostate Cancer Genetics. "The mapping 
information provided by these researchers will provide essential 
information necessary for the ultimate identification of the genes 
involved, and hopefully for mechanistically based efforts to address 
this disparity." 

The AAHPC was a collaborative effort involving 12 institutions 
nationwide including TGen; Fox Chase Cancer Center; NHGRI; the 
Comprehensive Cancer Center at the Ohio State University in 
Columbus; the National Human Genome Center, the Department of 
Microbiology and the Division of Urology at Howard University, 
Washington; Midtown Urology in Atlanta, the Columbia-Presbyterian 
Medical Center in New York; the Michael Reese Hospital in Chicago; 
the MD Anderson Medical Center in Houston; the University of 
Illinois in Chicago; the University of South Carolina in Columbia; 
and the Karmanos Cancer Institute, Wayne State University in 
Detroit. 

How to Create a Family Health History
To help people in the task of creating their family health 
histories, the U.S. Department of Heath and Human Services offers a 
free, computerized tool that organizes health information into a 
printout that can be can taken to health-care professionals. The 
tool, called "My Family Health Portrait," is available at 
https://familyhistory.hhs.gov/. 

# # # 

About TGen
The Translational Genomics Research Institute (TGen), a non-profit 
501(c)(3) organization, is focused on developing earlier diagnostics 
and smarter treatments. Translational genomics research is a 
relatively new field employing innovative advances arising from the 
Human Genome Project and applying them to the development of 
diagnostics, prognostics and therapies for cancer, neurological 
disorders, diabetes and other complex diseases. TGen's research is 
based on personalized medicine and the institute plans to accomplish 
its goals through robust and disease-focused research. 








http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
 
Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
    Individual Email | Traditional

<*> To change settings online go to:
    http://groups.yahoo.com/group/biotech-news/join
    (Yahoo! ID required)

<*> To change settings via email:
    mailto:[EMAIL PROTECTED] 
    mailto:[EMAIL PROTECTED]

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 

Reply via email to